PeƱalosa, Jovelyn U.

HRN: 18-51-03  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2026
MUPIROCIN 2%, 15G (TUBE)
02/19/2026
02/26/2026
SKIN
2%
BID
LSTCS
Checking Initial Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines